Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan

• WATANABE Sumio

  Department of Gastroenterology, Juntendo University School of Medicine

• ENOMOTO Nobuyuki

  First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi

• KOIKE Kazuhiko

  Department of Gastroenterology, Graduate School of Medicine, the University of Tokyo

• IZUMI Namiki

  Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital

• TAKIKAWA Hajime

  Department of Medicine, Teikyo University School of Medicine

• HASHIMOTO Etsuko

  Department of Medicine and Gastroenterology, Tokyo Women's Medical University

• MORIYASU Fuminori

  Department of Gastroenterology and Hepatology, Tokyo Medical University

• KUMADA Hiromitsu

  Department of Hepatology, Toranomon Hospital

• IMAWARI Michio

  Department of Gastroenterology, Showa University School of Medicine

• PERFECT Study Group

収録刊行物

• Hepatology research : the official journal of the Japan Society of Hepatology

  Hepatology research : the official journal of the Japan Society of Hepatology 40 (2), 135-144, 2010-02-01

キーワード

• chronic hepatitis C virus
• elderly patients
• pegylated interferon
• prolonged treatment
• ribavirin

詳細情報

• CRID: 1572543026081290624
• NII論文ID: 10027407197
• NII書誌ID: AA11140867
• ISSN: 13866346
• Web Site: https://search.jamas.or.jp/link/ui/2010180607
• 本文言語コード: en
• データソース種別:
  • CiNii Articles